about
Different Toll-Like Receptor Expression Patterns in Progression toward CancerAnti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors.Concomitant tumor expression of EGFR and TATI/SPINK1 associates with better prognosis in colorectal cancer.Autologous adipose stem cells and polylactide discs in the replacement of the rabbit temporomandibular joint disc.Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.A comparative study of two PODXL antibodies in 840 colorectal cancer patients.Rapidly growing and ulcerating metastatic renal cell carcinoma of the lower lip: A case report and review of the literature.REG4 independently predicts better prognosis in non-mucinous colorectal cancer.Podocalyxin is a marker of poor prognosis in colorectal cancerN-glycomic profiling as a tool to separate rectal adenomas from carcinomas.Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.Podocalyxin as a Prognostic Marker in Gastric CancerPROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.Expression of Toll-like receptors in nasal epithelium in allergic rhinitisTransketolase-like protein 1 expression predicts poor prognosis in colorectal cancer.Histopathological findings in parotid gland metastases from renal cell carcinoma.The changing surgical management of juvenile nasopharyngeal angiofibroma.Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.Experience of head and neck extracranial schwannomas in a whole population-based single-center patient series.Tumour budding in head and neck squamous cell carcinoma - a systematic review.A two-decade experience of head and neck paragangliomas in a whole population-based single centre cohort.Testing for high-risk HPV in cervical and tonsillar paraffin-embedded tissue using a cartridge-based assay.Pattern of recurrent disease in major salivary gland adenocystic carcinoma.Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.Toll-like receptors -4 and -5 in oral and cutaneous squamous cell carcinomas.Is p16 an adequate surrogate for human papillomavirus status determination?Systemic matrix metalloproteinase-8 response in chronic tonsillitis.Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresiaHuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors.The presence of minor salivary glands in the peritonsillar space.Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.TLR1-10, NF-κB and p53 expression is increased in oral lichenoid disease.Association of BMI-1 and p16 as prognostic factors for head and neck carcinomas.Does securin expression have significance in prognostication of oral tongue cancer? A pilot study.Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands.For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality.Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
P50
Q28085163-DBC043B5-2AB7-43EE-98FC-76D273B591ACQ30009992-986AB1D3-09AC-416C-A18B-D8BAF33E1A12Q30433526-4B13D975-D59D-4DA7-B7C5-A96EF90E8B3BQ31143290-2E2647B9-250C-4DB2-A8CE-F785C06D6FEAQ33704963-B3D86976-6C6E-4800-9DB2-05B9BF1656C9Q33708108-EC5C79B3-4510-4373-B14F-70F0AC8EF797Q33938468-90BAE436-4314-4A6D-B6CE-6B3A66D2B333Q34292957-B01678B8-F8FE-4C81-A1C2-3E9199F80CC3Q34309021-F453FA2B-4458-4748-A815-E553BC980B22Q34485223-9E52EC0C-3A08-466F-8445-09B1A74EEEF9Q35148539-22540036-FDEF-4968-8BFA-9B158AEEC3B3Q35656610-2CCE2459-1070-4844-B712-EFA4B69427B0Q35870705-762A7805-A248-4AF7-95D9-BA8A27A553D3Q36076312-C3294AD0-3BE1-458B-A337-63CDD1E414C7Q36554439-34DF2A28-7508-4160-B97A-BFDF3F03EFA6Q36844279-0313A09B-6614-4CE0-BFF5-009092BBD55AQ37148374-A29181F9-9D90-4F90-A013-5996CEBC3263Q37789641-A199A92B-A8E7-4FDC-ABC1-70354250483DQ37794441-AE4E47C5-3791-4891-BAE3-7F8F82E3557DQ38175282-64CD91CD-9694-46BC-92CF-F448D85E6332Q38217654-4D4CE89C-AC8F-4F4C-A81C-4AD8C0F3235DQ38224062-78FCEF43-E808-443F-BB46-AB5016EB1AF0Q38372919-298A541B-6E51-45F6-9F03-80C2C004684AQ38403166-52C23D7F-79D4-4A0A-8009-3F3BAFCB5E33Q38831072-9608CCD2-7737-4AA8-B520-9E05325D29B3Q38879048-6E936505-3C50-4AD5-AA18-11B0FC803B35Q38945757-54D94C14-8A16-42D5-A682-B307A9B060D7Q38973178-7C90B2B6-9E32-4B38-8202-5972C788C73AQ39111763-9E67DD1B-7CC2-48E3-9662-32226997A6E5Q39224925-E34AEF4E-8C32-4825-83F7-ABFEDF238B86Q39514189-E52E142D-2269-40ED-8269-623332B4BAF2Q39644661-8A297BE8-6D92-4A49-A9BD-3CFE205C09B4Q40049950-6DD47FB2-8769-4C54-96CE-9165726536BBQ40063898-E875F624-A9FD-4F41-AC67-DD129DCA7676Q40131966-EBB21555-329F-4DB4-87A7-38FEAC13E256Q40725395-31A82888-DC28-4A3B-894E-6E786BE4173FQ40793320-DF1E9B1C-9A11-4F8B-BDED-28F2797232BEQ40903431-A23FB82A-A320-4CA5-818D-4ABC513973C0Q41119827-EAF2A135-0D16-45FC-A201-DF28CD68CB60Q41412595-69B11128-E44E-4BA4-BF4B-9BB75B9D5B6F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jaana Hagström
@ast
Jaana Hagström
@en
Jaana Hagström
@es
Jaana Hagström
@nl
type
label
Jaana Hagström
@ast
Jaana Hagström
@en
Jaana Hagström
@es
Jaana Hagström
@nl
prefLabel
Jaana Hagström
@ast
Jaana Hagström
@en
Jaana Hagström
@es
Jaana Hagström
@nl
P106
P31
P496
0000-0001-6079-7881